Negative progesterone receptor status correlates with increased risk of breast cancer recurrence in luminal B HER2-positive and -negative subtypes
Objectives: The prognostic significance of the progesterone receptor (PR) has been widely investigated in luminal A and luminal B [human epidermal growth factor receptor 2 (HER2)–] breast cancer subtypes, both of which are estrogen receptor (ER)-positive and HER2-negative. In contrast, few studies h...
Guardado en:
Autores principales: | Toshiaki Utsumi, Naomi Kobayashi, Masahiro Hikichi, Kaori Ushimado, Makoto Kuroda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Fujita Medical Society
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/96109edb93504573b01a0e8c7eb32a00 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Application of preoperative ultrasound features combined with clinical factors in predicting HER2-positive subtype (non-luminal) breast cancer
por: Jin Zhou, et al.
Publicado: (2021) -
ASSOCIATION OF HORMONE RECEPTORS WITH RISK FACTORS AMONG BREAST CANCER PATIENTS
por: Ummara Aslam, et al.
Publicado: (2021) -
The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer
por: Alba Orea-Soufi, et al.
Publicado: (2021) -
Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site
por: Lower EE, et al.
Publicado: (2017) -
The prognostic value of quantitative analysis of CCL5 and collagen IV in luminal B (HER2–) subtype breast cancer by quantum-dot-based molecular imaging
por: Zhu YY, et al.
Publicado: (2018)